There’s been an explosion of digital therapeutics progressing with their paths-to-market. And three big insights are driving the success of digital therapeutics. Though there are still opportunities to disappoint, especially around one particular area.
There are enough challenges in healthcare where a good digitization of a process can increase engagement, improve connections to services and content, and provide a foundation to scale and deliver better care. Innovation doesn’t have to require AI, chatbots, complex analytics, or the latest emerging tech. Here are four companies who took existing paper-based processes and worked hard on a great digital experience to help the customer and patient and deliver an incredible impact on care
Tough times at Nokia and Fitbit suggest the strongest digital health strategy will be one that takes a systems and multi-vendor view, weaving in devices, assistive software, and caregivers with a business model that providers can understand and like.
I always value studies or feedback that validate the insights I have developed over the many years of selling to healthcare. Indeed, when I advise companies, many who are trying to wrap their head with the eccentricities of healthcare, having examples that go beyond my own experience is important. The study report is short, so I suggest you to read it. Nonetheless, I’ve highlighted a few of items for you.
We need to get better bridging innovators with nifty tech that can help healthcare and the folks on the inside who are trying to learn how the nifty tech can help; including the users in our development process, but not just the product aspects for product development, but the business model aspects for the customer development part; deploying solutions, keeping in mind that the pilot is a milestone on a path to usage and sales.
Continuous Evidence is the fusion of RWE, digital health, post-approval proof, and patient insight. How do you balance your needs for better insights with the needs and interests of the individuals you are helping?